Story at a Glance
- Some are calling berberine “nature’s Ozempic,” a once-weekly injectable diabetes medication that has grown in popularity as a weight loss product. Semaglutide is marketed as Ozempic for diabetes and in higher doses as Wegovy for weight loss.
- Data show adverse side effects include anxiety, confusion, depression, nightmares, seizures, and slurred speech. The tablet form has a boxed warning, as it’s known to increase the risk of thyroid growths, and data show that after withdrawal of the drug, most people regain at least two-thirds of their weight loss.
- Berberine works by helping to regulate blood sugar and improve insulin sensitivity and gut microbiome diversity that may contribute to weight loss. Data show berberine has a positive effect on lipid profile, fasting blood glucose, obesity parameters, and systolic blood pressure.
- Berberine helps prevent diarrhea, lowers the risk of leaky gut, nourishes beneficial microbes, and improves symptoms of fatty liver disease. Other beneficial effects include easing symptoms of anxiety and depression, improving symptoms of PTSD in an animal model, and easing symptoms of opioid withdrawal.
Prescriptions for semaglutide have doubled since mid-2021, rising to more than 1.2 million. In April 2023, a spokesperson for Novo Nordisk, maker of semaglutide, said the drugs are now available in pharmacies nationwide. Semaglutide is sold under the name Ozempic as a diabetes drug and under the name Wegovy as a weight loss prescription drug.
The list of potential issues includes that supplements are not reviewed or approved by the U.S. Food and Drug Administration (FDA), may not be safe for consumption, and that people who experience weight loss with berberine should stop immediately and consult with their physician as it suggests the supplement may have been adulterated.

Berberine Helps Regulate Blood Sugar and Aids Gut Microbiome
Research data show that berberine helps regulate blood sugar and may help with weight loss. A 2022 systematic review of the literature7 evaluated randomized controlled trials of adults given berberine supplementation. The pooled results demonstrated that berberine did reduce insulin levels, and the optimal dose given in these studies was 1 gram per day.In other words, if you are insulin resistant, you can improve insulin sensitivity through weight loss, but weight loss is more difficult.
- Prevent diarrhea by delaying the amount of time it takes for food to pass through your small intestine.18
- Lower your risk of leaky gut.19
- Preferentially nourish microbes that produce beneficial short-chain fatty acids, known to have many health benefits.20
- Improve symptoms of fatty liver disease by normalizing the gut microbiome.21

Semaglutide: Long-Term Results and Adverse Effects
Ozempic and Wegovy are both semaglutide, but Wegovy, which is approved for weight management, is a higher dose. The drug is a GLP-1 agonist that is available as a prefilled pen injector used once weekly. It stimulates the pancreas to release insulin, slows the gastrointestinal tract so you feel full longer, and may directly affect appetite control in your brain.22Both medications have a boxed warning when used in tablet form, as the drug is known to increase the risk of thyroid C-cell tumors in rodent testing. Because of this, the drug is contraindicated in patients with a personal or family history of multiple endocrine neoplasia type 2 (MEN2) or medullary thyroid carcinoma.
Berberine Affects Insulin Resistance in the Liver
Recent evidence has suggested that trimethylamine-N-oxide (TMAO) is a therapeutic target for insulin resistance and gastrointestinal cancers. A 2017 scientific review33 noted that gut bacteria form metabolites that contribute to developing cancer and insulin resistance, and TMAO is one molecule that may be a biomarker or an independent risk factor for insulin resistance.“TMAO arises when dietary choline and carnitine is metabolized by gastrointestinal bacteria to yield trimethylamine, which is then absorbed and oxidized to TMAO by hepatic flavin monooxygenases (FMO), primarily FMO3 … subnormal hepatic insulin activity, as found in those with hepatic [liver] insulin resistance, boosts hepatic FMO3 expression and hence TMAO levels.”If elevated TMAO reflects hepatic insulin resistance, which in turn raises your risk of cardiovascular disease and Type 2 diabetes, what can you do to correct it and lower your risk?
Anxiety, Depression, and Drug Withdrawal
Berberine has other beneficial health effects, including easing symptoms of anxiety and depression. This function may again be related to low levels of AMPK, which is linked to mitochondrial dysfunction, neurodegeneration, and chronic inflammation. These lay the groundwork for a wide variety of serious chronic diseases.“These results suggest that BER (berberine) had anxiolytic-like effects on behavioral and biochemical measures associated with anxiety. These findings support a role for reduced anxiety altered DAergic transmission and reduced anxiety in rats with PTSD. Thus, BER may be a useful agent to treat or alleviate psychiatric disorders like those observed in patients with PTSD.”Berberine has also been shown to activate Sigma1 receptors, a subclass of opioid receptors that react to morphine and similar substances—including those produced naturally in your body —and inhibit glutamate, thereby improving anxiety and depression.43 Sigma1 receptors play a role in oxidative stress, the functioning of your nervous system, and the survival of neurons, and as such, are believed to influence neuropsychiatric problems.44
The results of the study demonstrated that berberine could significantly reduce withdrawal-associated behaviors from morphine after the drug was discontinued. Researchers hypothesized that this potentially was by modulating the hypothalamic corticotrophin-releasing factor and the central noradrenergic system. They proposed that berberine could be useful for treating or alleviating withdrawal symptoms and preventing morphine use relapse.
◇ References
- 1, 4, 8, 14 The New York Times, June 7, 2023
- 2 AP News, April 30, 2023
- 3 Examine, Berberine
- 5 Supplements in Review, July 18, 2017
- 6 NBC News, July 1, 2023
- 7 Frontiers in Nutrition, 2022; 9
- 9 Journal of Physiology, 2009; 587(Pt. 20)
- 10 Journal of Clinical Medicine, 2019;8(10)
- 11 Nature, 2020;11(1841)
- 12 Science Daily, April 24, 2020, highlight and top para
- 13 Frontiers in Nutrition, 2022; 9 Abstract
- 15 Gut Microbes, 2022;14(1)
- 16 Genes, 2018;9(3)
- 17 Frontiers in Cellular and Infection Microbiology, 2022;12(854885)
- 18 Zhongguo Zhong Xi Yi Jie He Za Zhi. 1994;14(12)
- 19 Journal of Infectious Diseases 2011;203(11)
- 20 Scientific Reports 2015;5
- 21 Archives of Iranian Medicine 2016;19(3)
- 22, 23 GoodRx Health, April 26, 2023
- 24, 27 New England Journal of Medicine, 2021; 384
- 25 Nature Medicine, 2022; 28
- 26 Diabetes, Obesity and Metabolism, April 19, 2022
- 28 The Lancet, 2017;5(4)
- 29 Drugs.com, Ozempic
- 30 Drugs.com, Wegovy
- 31 Drugs.com, Wegovy, subheads ocular and immunologic
- 32 GoodRx, Wegovy
- 33 Current Pharmaceutical Design, 2017;23(25)
- 34, 35 Open Heart, 2019;6(1)
- 36 Oncotarget, 2018;9(11)
- 37 American Journal of Physiology, 1999;277(1)
- 38 Molecular Cell, 2017;66(6)
- 39 Endocrine, Metabolic and Immune Disorders Drug Targets 2008;8(2)
- 40 Journal of Ethnopharmacology, 2015;161
- 41 European Journal of Pharmacology, 2008;589(1-3)
- 42 Korean Journal of Physiology and Pharmacology, 2018;22(2)
- 43 News Max, January 25, 2017
- 44 Journal of Pharmacological Sciences, 2015;127(1)
- 45 Korean Journal of Physiology and Pharmacology, 2012; 16(6)
- 46 US News, December 15, 2022